Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype

Elisabeth J. Rushing, Daniel F. Brown, Christa L. Hladik, Richard C. Risser, Bruce E. Mickey, Charles L. White

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

In this study, we report our results on the proliferative activity of ependymomas as determined by MIB-1 (also known as Ki-67) immunohistochemical analysis, and we compare our results with those obtained by immunolabeling with monoclonal antibodies to p53 and bcl-2 proteins to assess whether expression correlated with ependymoma subtype or tumor grade. The study included 4 myxopapillary ependymomas (Grade I of the World Health Organization [WHO] scale), 10 subependymomas (WHO Grade I), 17 ependymomas (WHO Grade II), 2 papillary ependymomas (WHO grade II), and 4 anaplastic ependymomas (WHO Grade III). The MIB-1 proliferation index was significantly higher in tumors diagnosed as anaplastic ependymoma (P < .001), with a moderate level of correlation (Kendall's τ-b = 0.557, asymptotic standard error = 108). In addition, one ependymoma (WHO Grade II) not considered overtly anaplastic by routine histologic criteria showed a high MIB-1 labeling index, suggesting that the MIB-1 proliferation index might be a more objective indicator of tumor grade. The remaining WHO Grade I and Grade II ependymomas showed low proliferative activity. bcl-2 oncoprotein expression was identified in all of the four myxopapillary and in both papillary ependymomas. An additional observation was the correlation of p53 expression with increasing WHO grade. These data suggest that high MIB-1 and p53 immunolabeling might be objective indicators of high grade in ependymomas that do not otherwise meet routine histologic criteria for high-grade ependymoma. Subsequent clinicopathologic analyses will be important in assessing whether these markers are useful as independent predictors of survival.

Original languageEnglish (US)
Pages (from-to)464-470
Number of pages7
JournalModern Pathology
Volume11
Issue number5
StatePublished - May 1998

Fingerprint

Ependymoma
Subependymal Glioma
Neoplasms
Oncogene Proteins

Keywords

  • Bcl-2
  • Ependymoma
  • MIB-1
  • P53

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Rushing, E. J., Brown, D. F., Hladik, C. L., Risser, R. C., Mickey, B. E., & White, C. L. (1998). Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. Modern Pathology, 11(5), 464-470.

Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. / Rushing, Elisabeth J.; Brown, Daniel F.; Hladik, Christa L.; Risser, Richard C.; Mickey, Bruce E.; White, Charles L.

In: Modern Pathology, Vol. 11, No. 5, 05.1998, p. 464-470.

Research output: Contribution to journalArticle

Rushing, EJ, Brown, DF, Hladik, CL, Risser, RC, Mickey, BE & White, CL 1998, 'Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype', Modern Pathology, vol. 11, no. 5, pp. 464-470.
Rushing, Elisabeth J. ; Brown, Daniel F. ; Hladik, Christa L. ; Risser, Richard C. ; Mickey, Bruce E. ; White, Charles L. / Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. In: Modern Pathology. 1998 ; Vol. 11, No. 5. pp. 464-470.
@article{1de3eff7aeff40789f675ba2659ecc43,
title = "Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype",
abstract = "In this study, we report our results on the proliferative activity of ependymomas as determined by MIB-1 (also known as Ki-67) immunohistochemical analysis, and we compare our results with those obtained by immunolabeling with monoclonal antibodies to p53 and bcl-2 proteins to assess whether expression correlated with ependymoma subtype or tumor grade. The study included 4 myxopapillary ependymomas (Grade I of the World Health Organization [WHO] scale), 10 subependymomas (WHO Grade I), 17 ependymomas (WHO Grade II), 2 papillary ependymomas (WHO grade II), and 4 anaplastic ependymomas (WHO Grade III). The MIB-1 proliferation index was significantly higher in tumors diagnosed as anaplastic ependymoma (P < .001), with a moderate level of correlation (Kendall's τ-b = 0.557, asymptotic standard error = 108). In addition, one ependymoma (WHO Grade II) not considered overtly anaplastic by routine histologic criteria showed a high MIB-1 labeling index, suggesting that the MIB-1 proliferation index might be a more objective indicator of tumor grade. The remaining WHO Grade I and Grade II ependymomas showed low proliferative activity. bcl-2 oncoprotein expression was identified in all of the four myxopapillary and in both papillary ependymomas. An additional observation was the correlation of p53 expression with increasing WHO grade. These data suggest that high MIB-1 and p53 immunolabeling might be objective indicators of high grade in ependymomas that do not otherwise meet routine histologic criteria for high-grade ependymoma. Subsequent clinicopathologic analyses will be important in assessing whether these markers are useful as independent predictors of survival.",
keywords = "Bcl-2, Ependymoma, MIB-1, P53",
author = "Rushing, {Elisabeth J.} and Brown, {Daniel F.} and Hladik, {Christa L.} and Risser, {Richard C.} and Mickey, {Bruce E.} and White, {Charles L.}",
year = "1998",
month = "5",
language = "English (US)",
volume = "11",
pages = "464--470",
journal = "Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype

AU - Rushing, Elisabeth J.

AU - Brown, Daniel F.

AU - Hladik, Christa L.

AU - Risser, Richard C.

AU - Mickey, Bruce E.

AU - White, Charles L.

PY - 1998/5

Y1 - 1998/5

N2 - In this study, we report our results on the proliferative activity of ependymomas as determined by MIB-1 (also known as Ki-67) immunohistochemical analysis, and we compare our results with those obtained by immunolabeling with monoclonal antibodies to p53 and bcl-2 proteins to assess whether expression correlated with ependymoma subtype or tumor grade. The study included 4 myxopapillary ependymomas (Grade I of the World Health Organization [WHO] scale), 10 subependymomas (WHO Grade I), 17 ependymomas (WHO Grade II), 2 papillary ependymomas (WHO grade II), and 4 anaplastic ependymomas (WHO Grade III). The MIB-1 proliferation index was significantly higher in tumors diagnosed as anaplastic ependymoma (P < .001), with a moderate level of correlation (Kendall's τ-b = 0.557, asymptotic standard error = 108). In addition, one ependymoma (WHO Grade II) not considered overtly anaplastic by routine histologic criteria showed a high MIB-1 labeling index, suggesting that the MIB-1 proliferation index might be a more objective indicator of tumor grade. The remaining WHO Grade I and Grade II ependymomas showed low proliferative activity. bcl-2 oncoprotein expression was identified in all of the four myxopapillary and in both papillary ependymomas. An additional observation was the correlation of p53 expression with increasing WHO grade. These data suggest that high MIB-1 and p53 immunolabeling might be objective indicators of high grade in ependymomas that do not otherwise meet routine histologic criteria for high-grade ependymoma. Subsequent clinicopathologic analyses will be important in assessing whether these markers are useful as independent predictors of survival.

AB - In this study, we report our results on the proliferative activity of ependymomas as determined by MIB-1 (also known as Ki-67) immunohistochemical analysis, and we compare our results with those obtained by immunolabeling with monoclonal antibodies to p53 and bcl-2 proteins to assess whether expression correlated with ependymoma subtype or tumor grade. The study included 4 myxopapillary ependymomas (Grade I of the World Health Organization [WHO] scale), 10 subependymomas (WHO Grade I), 17 ependymomas (WHO Grade II), 2 papillary ependymomas (WHO grade II), and 4 anaplastic ependymomas (WHO Grade III). The MIB-1 proliferation index was significantly higher in tumors diagnosed as anaplastic ependymoma (P < .001), with a moderate level of correlation (Kendall's τ-b = 0.557, asymptotic standard error = 108). In addition, one ependymoma (WHO Grade II) not considered overtly anaplastic by routine histologic criteria showed a high MIB-1 labeling index, suggesting that the MIB-1 proliferation index might be a more objective indicator of tumor grade. The remaining WHO Grade I and Grade II ependymomas showed low proliferative activity. bcl-2 oncoprotein expression was identified in all of the four myxopapillary and in both papillary ependymomas. An additional observation was the correlation of p53 expression with increasing WHO grade. These data suggest that high MIB-1 and p53 immunolabeling might be objective indicators of high grade in ependymomas that do not otherwise meet routine histologic criteria for high-grade ependymoma. Subsequent clinicopathologic analyses will be important in assessing whether these markers are useful as independent predictors of survival.

KW - Bcl-2

KW - Ependymoma

KW - MIB-1

KW - P53

UR - http://www.scopus.com/inward/record.url?scp=0031955237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031955237&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 464

EP - 470

JO - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

JF - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

SN - 0893-3952

IS - 5

ER -